We need all countries 🌎 to work together now to control the rise in antimicrobial resistance so we can continue to rely on these drugs 💊 to treat diseases and prevent an unprecedented crisis.
That’s a core focus of PAHO’s Strategic Fund, which helps countries keep the costs 💰 of drugs, medicines and products under control and ensure adequate supply, so these tools are available when patients need them most.
Just as we were able to channel our collective capacity to develop diagnostics and 💉 for COVID in record time, we need commitment & collaboration to develop new and affordable antimicrobials
Any new 💊 must be accessible to countries, regardless of income
Antimicrobials 💊 are still being misused to treat COVID infections, so countries must promote clear, evidence-based treatment guidelines so clinicians 👨🏾⚕️👩🏻⚕️ know when these drugs are recommended.
We’ve been pleased to see many countries maintain and expand their surveillance systems during the pandemic, and we encourage them to leverage these lab 🔬networks to track antimicrobials resistance 🧫 for the foreseeable future.
